Target intelligence / Profile preview

Defective pharyngeal development protein 4 (PHA-4)

Target
PHA-4
Molecular classification
Transcription factor, Forkhead/FOXA family
01

Overview

Defective pharyngeal development protein 4 (PHA-4) is a highly conserved transcription factor of the Forkhead box A (FOXA) family found in Caenorhabditis elegans[3][4][5]. PHA-4 functions as a master regulator of organogenesis for the pharynx and rectum during embryogenesis, with expression predominantly in the developing pharynx across all its cell types[3][4]. It directly binds DNA to control the expression of key developmental genes and acts as a central regulator integrating environmental cues, such as dietary restriction, to control gene networks impacting longevity, metabolism, stress resistance, and lipid homeostasis[1][2][5][7]. PHA-4 mediates complex feed-forward loops, regulating both protein-coding genes and microRNAs, especially under energetic stress[1][2]. Although extensively studied for its roles in development and aging, it is not a direct therapeutic target and has no approved drug modulators, though the related human FOXA factors have roles in metabolism and cancer[2][4][5][7].

Other names
Ce-fkh-1FOXAfork head/HNF-3 alpha, beta, gamma orthologdefective PHArynx development 4
02

Biological functions

Regulation of pharynx and rectum developmentTranscriptional regulation of gene expressionMediator of dietary restriction-induced longevityControl of metabolism and lipid accumulationRegulation of protein folding, autophagy, and cellular stress responses
03

Disease associations

Aging/longevity regulationOther (not directly disease-causing in C. elegans, but crucial in developmental and longevity pathways)

Beyond the preview

Go deeper on Defective pharyngeal development protein 4 (PHA-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defective pharyngeal development protein 4 (PHA-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call